Results 181 to 190 of about 205,622 (234)

Mutational Disruption of TP53: A Structural Approach to Understanding Chemoresistance. [PDF]

Int J Mol Sci
Alsulami AF.
europepmc   +1 more source

RSPO4 exerts tumor suppression through antagonizing canonical and non-canonical Wnt signaling. [PDF]

Int J Biol Sci
Du Z, Li L, Shu X, Li C, Tao Q.
europepmc   +1 more source

Drivers and implications of lineage-specific cancer-related mutations in human pluripotent and adult stem cells. [PDF]

Stem Cell Reports
Jung J, Benvenisty N.
europepmc   +1 more source

GETgene-AI: a framework for prioritizing actionable cancer drug targets. [PDF]

Front Syst Biol
Gu A, Chen JY.
europepmc   +1 more source

Molecular analysis of the evolutionary history of endometrial and ovarian carcinoma in Lynch syndrome. [PDF]

Int J Cancer
Kauppinen AK, Olkinuora AP, Mecklin JP, Peltomäki PT.   +3 more
europepmc   +1 more source

UVA-induced DNA damage and mutations in human melanocytes: relevance for melanoma mutations. [PDF]

Nucleic Acids Res
Jin SG, Johnson J, Kim PY, Pfeifer GP.
europepmc   +1 more source

DeepTarget predicts anti-cancer mechanisms of action of small molecules by integrating drug and genetic screens. [PDF]

NPJ Precis Oncol
Sinha S, Sinha N, Perales M, Tarrab A, Nguyen T, Liu L, Cantore T, Alvarez K, Patiyal S, Mukherjee S, Madan S, Tharp K, Zhao J, Kumar R, Flanigan G, Beutler JA, O'Keefe BR, Meerzaman D, Ben-David U, Deshpande AJ, Ruppin E.   +20 more
europepmc   +1 more source

Machine Learning-Driven Integration of Cancer Cell Phenotypes Predicts Cisplatin Sensitivity. [PDF]

Cancer Med
Ujiie H, Sakyo T, Oya K, Sugawara Y, Ota M, Yonezawa H, Nishiya N.   +6 more
europepmc   +1 more source

Predicted functional consequences of WNT ligand mutations in colorectal cancer. [PDF]

Biophys J
Ahmed A, Shorthouse D.
europepmc   +1 more source